Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Mar. 31, 2017
USD ($)
| |
| Beginning balance | $ 430,882 |
| Acquisitions (Note 3) | 141,557 |
| Prior year acquisitions (Note 3) | 1,809 |
| Currency translation | (4,510) |
| Ending balance | 569,738 |
| Biotechnology [Member] | |
| Beginning balance | 108,802 |
| Acquisitions (Note 3) | 141,557 |
| Prior year acquisitions (Note 3) | |
| Currency translation | (2,633) |
| Ending balance | 247,726 |
| Diagnostics [Member] | |
| Beginning balance | 103,270 |
| Acquisitions (Note 3) | |
| Prior year acquisitions (Note 3) | |
| Currency translation | |
| Ending balance | 103,270 |
| Protein Platforms [Member] | |
| Beginning balance | 218,810 |
| Acquisitions (Note 3) | |
| Prior year acquisitions (Note 3) | 1,809 |
| Currency translation | (1,877) |
| Ending balance | $ 218,742 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|